BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24014082)

  • 21. p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters.
    Fischer CA; Kampmann M; Zlobec I; Green E; Tornillo L; Lugli A; Wolfensberger M; Terracciano LM
    Ann Oncol; 2010 Oct; 21(10):1961-1966. PubMed ID: 20423915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human papillomavirus E7 serology and association with p16 immunohistochemistry in squamous cell carcinoma of the head and neck.
    Khanal S; Joh J; Kwon AM; Zahin M; Perez CA; Dunlap NE; Silverman CL; Tennant PA; Potts KL; Kloecker GH; Bumpous JM; Ghim SJ; Jenson AB; Redman RA
    Exp Mol Pathol; 2015 Oct; 99(2):335-40. PubMed ID: 26116154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p16INK4A expression as biomarker for HPV 16-related vulvar neoplasias.
    Riethdorf S; Neffen EF; Cviko A; Löning T; Crum CP; Riethdorf L
    Hum Pathol; 2004 Dec; 35(12):1477-83. PubMed ID: 15619206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathologic Features of Anal and Perianal Squamous Cell Carcinomas and Their Relationship to Human Papillomavirus.
    Ju JY; Stelow EB
    Am J Surg Pathol; 2019 Jun; 43(6):827-834. PubMed ID: 31091204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma.
    Young RJ; Urban D; Angel C; Corry J; Lyons B; Vallance N; Kleid S; Iseli TA; Solomon B; Rischin D
    Br J Cancer; 2015 Mar; 112(6):1098-104. PubMed ID: 25688737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of human papillomavirus in anal squamous cell carcinoma.
    Ravenda PS; Magni E; Botteri E; Manzotti M; Barberis M; Vacirca D; Trovato CM; Dell'Acqua V; Leonardi MC; Sideri M; Fazio N; Zampino MG
    Cancer Chemother Pharmacol; 2014 Nov; 74(5):1033-8. PubMed ID: 25209946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk stratification of early stage oral tongue cancers based on HPV status and p16 immunoexpression.
    Ramshankar V; Soundara VT; Shyamsundar V; Ramani P; Krishnamurthy A
    Asian Pac J Cancer Prev; 2014; 15(19):8351-9. PubMed ID: 25339028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide.
    Alemany L; Saunier M; Alvarado-Cabrero I; Quirós B; Salmeron J; Shin HR; Pirog EC; Guimerà N; Hernandez-Suarez G; Felix A; Clavero O; Lloveras B; Kasamatsu E; Goodman MT; Hernandez BY; Laco J; Tinoco L; Geraets DT; Lynch CF; Mandys V; Poljak M; Jach R; Verge J; Clavel C; Ndiaye C; Klaustermeier J; Cubilla A; Castellsagué X; Bravo IG; Pawlita M; Quint WG; Muñoz N; Bosch FX; de Sanjosé S;
    Int J Cancer; 2015 Jan; 136(1):98-107. PubMed ID: 24817381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oropharyngeal carcinoma: A single institution study of 338 primaries with special reference to high-risk human papillomavirus-mediated carcinoma with aggressive behavior.
    Alexiev BA; Obeidin F; Johnson DN; Finkelman BS; Prince R; Somani SN; Cheng E; Samant S
    Pathol Res Pract; 2020 Dec; 216(12):153243. PubMed ID: 33113454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection and significance of human papillomavirus, CDKN2A(p16) and CDKN1A(p21) expression in squamous cell carcinoma of the larynx.
    Chernock RD; Wang X; Gao G; Lewis JS; Zhang Q; Thorstad WL; El-Mofty SK
    Mod Pathol; 2013 Feb; 26(2):223-31. PubMed ID: 22996374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The overexpression of p16 is not a surrogate marker for high-risk human papilloma virus genotypes and predicts clinical outcomes for vulvar cancer.
    Sznurkowski JJ; Żawrocki A; Biernat W
    BMC Cancer; 2016 Jul; 16():465. PubMed ID: 27411473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Relationship between HPV-DNA status and p16 protein expression in oropharyngeal squamous cell carcinoma and their clinical significance].
    Huang H; Zhang B; Chen W; Zou SM; Xu ZG
    Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):684-8. PubMed ID: 24332056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic significance of tumor human papillomavirus status for patients with anal squamous cell carcinoma treated with combined chemoradiotherapy.
    Yhim HY; Lee NR; Song EK; Kwak JY; Lee ST; Kim JH; Kim JS; Park HS; Chung IJ; Shim HJ; Hwang JE; Kim HR; Nam TK; Park MR; Shim H; Park HS; Kim HS; Yim CY
    Int J Cancer; 2011 Oct; 129(7):1752-60. PubMed ID: 21128253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Histological characteristics of HPV-associated and -independent squamous cell carcinomas of the vulva: A study of 1,594 cases".
    Rakislova N; Clavero O; Alemany L; Saco A; Quirós B; Lloveras B; Alejo M; Pawlita M; Quint W; Del Pino M; de Sanjose S; Ordi J;
    Int J Cancer; 2017 Dec; 141(12):2517-2527. PubMed ID: 28815579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human papillomavirus (HPV) and HPV 16-variant distribution in vulvar squamous cell carcinoma in Sweden.
    Larsson GL; Helenius G; Andersson S; Elgh F; Sorbe B; Karlsson MG
    Int J Gynecol Cancer; 2012 Oct; 22(8):1413-9. PubMed ID: 23013732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intensified intensity-modulated radiotherapy in anal cancer with prevalent HPV p16 positivity.
    Belgioia L; Vagge S; Agnese D; Garelli S; Murialdo R; Fornarini G; Chiara S; Gallo F; Bacigalupo A; Corvò R
    World J Gastroenterol; 2015 Oct; 21(37):10688-96. PubMed ID: 26457030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer.
    Reimers N; Kasper HU; Weissenborn SJ; Stützer H; Preuss SF; Hoffmann TK; Speel EJ; Dienes HP; Pfister HJ; Guntinas-Lichius O; Klussmann JP
    Int J Cancer; 2007 Apr; 120(8):1731-8. PubMed ID: 17236202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of human papillomavirus and p16(INK4a) on treatment outcome of patients with anal cancer.
    Koerber SA; Schoneweg C; Slynko A; Krug D; Haefner MF; Herfarth K; Debus J; Sterzing F; von Knebel Doeberitz M; Prigge ES; Reuschenbach M
    Radiother Oncol; 2014 Dec; 113(3):331-6. PubMed ID: 25465729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HPV-Associated Squamous Cell Carcinoma of the Eyelid: Diagnostic Utility of p16 Immunohistochemistry and mRNA In Situ Hybridization.
    Kakkar A; Srivastava K; Deepa S; Kashyap S; Sen S; Bhoriwal S; Kaur K; Deo SVS
    Head Neck Pathol; 2023 Dec; 17(4):889-898. PubMed ID: 37735287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HPV positive, wild type TP53, and p16 overexpression correlate with the absence of residual tumors after chemoradiotherapy in anal squamous cell carcinoma.
    Soares PC; Abdelhay ES; Thuler LCS; Soares BM; Demachki S; Ferro GVR; Assumpção PP; Lamarão LM; Ribeiro Pinto LF; Burbano RMR
    BMC Gastroenterol; 2018 Feb; 18(1):30. PubMed ID: 29466950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.